SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-23-010684 to GROOVE BOTANICALS INC. (GRVE) (CIK 0000918573) (GRVE)

GROOVE BOTANICALS INC. (GRVE) (CIK 0000918573)
Date: Sept. 27, 2023 · CIK: 0000918573 · Accession: 0000000000-23-010684

AI Filing Summary & Sentiment

File numbers found in text: 000-23476

Referenced dates: August 8, 2023

Date
September 27, 2023
Author
Not clearly detected
Form
UPLOAD
Company
GROOVE BOTANICALS INC. (GRVE) (CIK 0000918573)

Letter

United States securities and exchange commission logo September 27, 2023 Kent Rodriguez Chief Executive Officer, President Groove Botanicals Inc. 310 Fourth Avenue South, Suite 7000 Minneapolis, MN 55415 Re:Groove Botanicals Inc. Registration Statement on Form 10-12G Filed September 14, 2023 File No. 000-23476 Dear Kent Rodriguez: We have reviewed your filing and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to these comments within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe our comments apply to your facts and circumstances, please tell us why in your response. After reviewing your response and any amendment you may file in response to these comments, we may have additional comments. Unless we note otherwise, our references to prior comments are to comments in our August 8, 2023 letter. Registration Statement on Form 10-12G Item 14. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure, page 16 1.We note you did not revise your disclosure as previously requested in comment 1 in our letter dated August 8, 2023. Accordingly we re-issue our prior comment as follows: We read your response to prior comment 1, and do not agree with your assertion that no disclosure as required by Item 304(a)(1), (2) and (3) of Regulation S-K regarding Changes in and Disagreements with Accountants on Accounting and Financial Disclosure is required. Specifically, we note the following: •Although you state in your response that TAAD LLP did not complete an audit or issue any report, an audit opinion issued by TAAD LLP, dated April 12, 2023, on your financial statements for the years ended March 31, 2022 and 2021 was included

FirstName LastNameKent Rodriguez Comapany NameGroove Botanicals Inc. September 27, 2023 Page 2 FirstName LastName Kent Rodriguez Groove Botanicals Inc. September 27, 2023 Page 2 in the Form 10 you filed on April 13, 2023. If TADD LLP did not issue this audit report, please explain to us why you included such a report in the relevant filing. •You engaged TAAD LLP as your principal accountant to audit your financial statements and the disclosure required by Item 304(a) of Regulation S-K is required even if TAAD LLP did not complete an audit or issue any report. •You engaged B F Borgers, CPA, PC to audit your financial statements for the years ended March 31, 2023 and 2022 and their report dated June 15, 2023 is included in your current registration statement. Thus it appears you engaged a new independent accountant as the principal independent accountant to audit your financial statements for those periods. As previously requested, revise your registration statement to include all of the disclosures required by Item 304(a)(1), (2), and (3) of Regulation S-K and file the former accountant’s letter contemplated by Item 304(a)(3) of Regulation S-K as an exhibit to your registration statement.

You must provide the disclosures required by Item 304(b) of Regulation S-K, only if in connection with the change in accountants subject to Item 304(a) of Regulation S-K, there was any disagreement of the type described in paragraph (a)(1)(iv) or any reportable event as described in paragraph (a)(1)(v) of Item 304(a). Financial Statements General, page 17 2.Please amend your filing to update your financial statements and other financial information in accordance with Rule 8-08 of Regulation S-X. Consolidated Statements of Stockholders' Equity, page 20 3.Please revise your statements of stockholders’ equity to be presented for only the two-year period covered by the auditors’ report, i.e., for the years ended March 31, 2023 and 2022, and revise the title of such statements to reflect this revision. Note 2 - Summary of Significant Accounting Policies Basis of Presentation, page 22 4.Please revise to eliminate the reference to condensed financial statements. Notes to Financial Statements Note 1 - Organization and Operations Current Operations, page 22 5.Please revise the last sentence in the second paragraph under Current Operations to indicate that the audits of your 2022 and 2023 financial statements have been completed.

FirstName LastNameKent Rodriguez Comapany NameGroove Botanicals Inc. September 27, 2023 Page 3 FirstName LastName Kent Rodriguez Groove Botanicals Inc. September 27, 2023 Page 3 Note 11 - Commitments and Contingencies, page 30 6.We note you revised your audited financial statements to eliminate the paragraph previously included in this footnote regarding potential claims and disputes related to your business which had stated that your management does not believe that the outcome of any of the legal proceedings to which you are a party will have a material adverse effect on your financial position or results of operations. You also revised your audited financial statements to remove Note 12 – Subsequent Events. Please explain to us why you removed these disclosures.

Please also confirm to us that your auditor is aware of and approved of these revisions to your audited financial statements. Exhibits 7.There appears no such amendment to reflect the change of the company's name to "Groove Botanicals Inc." Under "Organizational History" on page 3 you disclose that on "May 14, 2018, the Corporation changed our name from Avalon Oil and Gas, Inc., to Groove Botanicals, Inc." Please file an Amended Articles of Incorporation that reflects your current name. 8.You disclose on page 27 that on July 18, 2022 Letter Agreements were drafted between the Company and the debtholder on both a $40,000 Convertible Promissory Note issued on March 5, 2021 and a $60,000 Convertible Promissory Note issued March 7, 2022, which establishes the settlement of each debt once the Company’s Form 10 goes effective. Please file these agreements establishing settlement of such debts. See Item 601(b)(4) of Regulation S-K. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. You may contact Sondra Snyder, Staff Accountant, at 202-551-3332 or Robert Babula, Staff Accountant, at 202-551-3339 if you have questions regarding comments on the financial statements and related matters. Please contact Michael Purcell, Staff Attorney, at 202-551-5351 or Kevin Dougherty, Staff Attorney, at 202-551-3271 with any other questions. Sincerely, Division of Corporation Finance Office of Energy & Transportation cc: Jack Brannelly

Show Raw Text
United States securities and exchange commission logo
September 27, 2023
Kent Rodriguez
Chief Executive Officer, President
Groove Botanicals Inc.
310 Fourth Avenue South, Suite 7000
Minneapolis, MN 55415
Re:Groove Botanicals Inc.
Registration Statement on Form 10-12G
Filed September 14, 2023
File No. 000-23476
Dear Kent Rodriguez:
            We have reviewed your filing and have the following comments.  In some of our
comments, we may ask you to provide us with information so we may better understand your
disclosure.
            Please respond to these comments within ten business days by providing the requested
information or advise us as soon as possible when you will respond.  If you do not believe our
comments apply to your facts and circumstances, please tell us why in your response.
            After reviewing your response and any amendment you may file in response to these
comments, we may have additional comments. Unless we note otherwise, our references to prior
comments are to comments in our August 8, 2023 letter.
Registration Statement on Form 10-12G
Item 14. Changes in and Disagreements with Accountants on Accounting and Financial
Disclosure, page 16
1.We note you did not revise your disclosure as previously requested in comment 1 in our
letter dated August 8, 2023.  Accordingly we re-issue our prior comment as follows:  We
read your response to prior comment 1, and do not agree with your assertion that no
disclosure as required by Item 304(a)(1), (2) and (3) of Regulation S-K regarding Changes
in and Disagreements with Accountants on Accounting and Financial Disclosure is
required.  Specifically, we note the following:
•Although you state in your response that TAAD LLP did not complete an audit or
issue any report, an audit opinion issued by TAAD LLP, dated April 12, 2023, on
your financial statements for the years ended March 31, 2022 and 2021 was included

 FirstName LastNameKent Rodriguez
 Comapany NameGroove Botanicals Inc.
 September 27, 2023 Page 2
 FirstName LastName
Kent Rodriguez
Groove Botanicals Inc.
September 27, 2023
Page 2
in the Form 10 you filed on April 13, 2023.  If TADD LLP did not issue this audit
report, please explain to us why you included such a report in the relevant filing.
•You engaged TAAD LLP as your principal accountant to audit your financial
statements and the disclosure required by Item 304(a) of Regulation S-K is required
even if TAAD LLP did not complete an audit or issue any report.
•You engaged B F Borgers, CPA, PC to audit your financial statements for the years
ended March 31, 2023 and 2022 and their report dated June 15, 2023 is included in
your current registration statement.  Thus it appears you engaged a new independent
accountant as the principal independent accountant to audit your financial statements
for those periods.
As previously requested, revise your registration statement to include all of the disclosures
required by Item 304(a)(1), (2), and (3) of Regulation S-K and file the former
accountant’s letter contemplated by Item 304(a)(3) of Regulation S-K as an exhibit to
your registration statement.

You must provide the disclosures required by Item 304(b) of Regulation S-K, only if in
connection with the change in accountants subject to Item 304(a) of Regulation S-K, there
was any disagreement of the type described in paragraph (a)(1)(iv) or any reportable event
as described in paragraph (a)(1)(v) of Item 304(a).
Financial Statements
General, page 17
2.Please amend your filing to update your financial statements and other financial
information in accordance with Rule 8-08 of Regulation S-X.
Consolidated Statements of Stockholders' Equity, page 20
3.Please revise your statements of stockholders’ equity to be presented for only the two-year
period covered by the auditors’ report, i.e., for the years ended March 31, 2023 and 2022,
and revise the title of such statements to reflect this revision.
Note 2 - Summary of Significant Accounting Policies
Basis of Presentation, page 22
4.Please revise to eliminate the reference to condensed financial statements.
Notes to Financial Statements
Note 1 - Organization and Operations
Current Operations, page 22
5.Please revise the last sentence in the second paragraph under Current Operations to
indicate that the audits of your 2022 and 2023 financial statements have been completed.

 FirstName LastNameKent Rodriguez
 Comapany NameGroove Botanicals Inc.
 September 27, 2023 Page 3
 FirstName LastName
Kent Rodriguez
Groove Botanicals Inc.
September 27, 2023
Page 3
Note 11 - Commitments and Contingencies, page 30
6.We note you revised your audited financial statements to eliminate the paragraph
previously included in this footnote regarding potential claims and disputes related to your
business which had stated that your management does not believe that the outcome of any
of the legal proceedings to which you are a party will have a material adverse effect on
your financial position or results of operations.  You also revised your audited financial
statements to remove Note 12 – Subsequent Events.  Please explain to us why you
removed these disclosures.

Please also confirm to us that your auditor is aware of and approved of these revisions to
your audited financial statements.
Exhibits
7.There appears no such amendment to reflect the change of the company's name to
"Groove Botanicals Inc." Under "Organizational History" on page 3 you disclose that
on "May 14, 2018, the Corporation changed our name from Avalon Oil and Gas, Inc., to
Groove Botanicals, Inc." Please file an Amended Articles of Incorporation that reflects
your current name.
8.You disclose on page 27 that on July 18, 2022 Letter Agreements were drafted between
the Company and the debtholder on both a $40,000 Convertible Promissory Note issued
on March 5, 2021 and a $60,000 Convertible Promissory Note issued March 7, 2022,
which establishes the settlement of each debt once the Company’s Form 10 goes effective.
Please file these agreements establishing settlement of such debts. See Item 601(b)(4) of
Regulation S-K.
            We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
            You may contact Sondra Snyder, Staff Accountant, at 202-551-3332 or Robert Babula,
Staff Accountant, at 202-551-3339 if you have questions regarding comments on the financial
statements and related matters. Please contact Michael Purcell, Staff Attorney, at 202-551-5351
or Kevin Dougherty, Staff Attorney, at 202-551-3271 with any other questions.
Sincerely,
Division of Corporation Finance
Office of Energy & Transportation
cc:       Jack Brannelly